Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Targeted Therapy in Chronic Lymphocytic Leukemia (CLL)
Erin M. Pettijohn,
Shuo Ma
*
*
Corresponding author for this work
Medicine, Hematology Oncology Division
Research output
:
Contribution to journal
›
Review article
›
peer-review
6
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Targeted Therapy in Chronic Lymphocytic Leukemia (CLL)'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
B-Cell Chronic Lymphocytic Leukemia
100%
Therapeutic Procedure
100%
Targeted Therapy
100%
Side Effect
25%
Protein
25%
Spontaneous Remission
25%
Chemotherapy
25%
Combination Therapy
25%
Phosphoinositide 3-Kinase
25%
Protein Tyrosine Kinase
25%
Chemoimmunotherapy
25%
Antiapoptotic
25%
B Lymphocyte Receptor
25%
Patient
25%
INIS
therapy
100%
leukemia
100%
kinases
50%
data
25%
patients
25%
risks
25%
proteins
25%
populations
25%
receptors
25%
tyrosine
25%
side effects
25%
chemotherapy
25%
boron chlorides
25%